new research reported from the lab of Markita Landry, a professor of chemical and biomolecular engineering at UC Berkeley, a team of scientists has taken an original approach of using DNA origami nanotechnology to slip through plant cell walls and graft small interfering RNA (siRNA) directly onto plant cells. Their research shows it is possible to directly silence genes in plants without damaging plant tissues, and without making any alterations to the plant’s genome.
For the first time ever, scientists have imaged the process by which an individual immune system molecule is switched on in response to a signal from the environment, leading to the critical discovery that the activation process involves hundreds of proteins suddenly coming together to form a linked network through a process known as a phase transition.
UC Berkeley synthetic biologists have engineered brewer’s yeast to produce marijuana’s main ingredients—mind-altering THC and non-psychoactive CBD—as well as novel cannabinoids not found in the plant itself. Medical research on the more than 100 other chemicals in marijuana has been difficult, because the chemicals occur in tiny quantities, making them hard to extract from the plant. Inexpensive, purer sources—like yeast—could make such studies easier.
Jennifer Doudna was awarded the Pearl Meister Greengard Prize in October 2018, established by Nobel Laureate Paul Greengard and his wife, the artist Ursula von Rydingsvard, to give recognition to women scientists. The New York Review spoke with her before the award ceremony. “That there even is a prize like this one,” Doudna said, “is a sign that people are really beginning to value the contributions of women to science.”
A statement about the U.S. Court of Appeals decision on the University of California's patent interference claim before the Patent Trial and Appeal Board b by Charles F. Robinson, Office of General Counsel, UC Office of the President.
Jnana Therapeutics today announced that UC Berkeley Chemistry alum Joanne Kotz, Ph.D., a company co-founder, has been named Chief Executive Officer. Dr. Kotz has served as Jnana's president since December 2017.
Frances H. Arnold, the Linus Pauling Professor of Chemical Engineering, Bioengineering and Biochemistry at Caltech, is one of three winners of the 2018 Nobel Prize in Chemistry.
An ancient group of microbes that contains some of the smallest life forms on Earth also has the smallest CRISPR gene-editing machinery discovered to date.
UC Berkeley synthetic biologists have engineered brewer’s yeast to produce marijuana’s main ingredients—mind-altering THC and non-psychoactive CBD—as well as novel cannabinoids not found in the plant itself. Medical research on the more than 100 other chemicals in marijuana has been difficult, because the chemicals occur in tiny quantities, making them hard to extract from the plant. Inexpensive, purer sources—like yeast—could make such studies easier. 
Jennifer Doudna was awarded the Pearl Meister Greengard Prize in October 2018, established by Nobel Laureate Paul Greengard and his wife, the artist Ursula von Rydingsvard, to give recognition to women scientists. The New York Review spoke with her before the award ceremony. “That there even is a prize like this one,” Doudna said, “is a sign that people are really beginning to value the contributions of women to science.” 
Jnana Therapeutics today announced that UC Berkeley Chemistry alum Joanne Kotz, Ph.D., a company co-founder, has been named Chief Executive Officer. Dr. Kotz has served as Jnana's president since December 2017.
JBEI researchers gain understanding of central metabolism of bacteria and yeast species commonly used in biotechnology.
Frances H. Arnold, the Linus Pauling Professor of Chemical Engineering, Bioengineering and Biochemistry at Caltech, is one of three winners of the 2018 Nobel Prize in Chemistry.
IGI researchers, including Bruce Conklin of UCSF and Jennifer Doudna of UC Berkeley, 